EcoDrugPlus

Dipeptidyl Peptidase 4

Ensembl ID : ENSCLAG00000002709
Gene Symbol: DPP4
2 Cross references
286 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSCLAG00000008308
Gene Symbol: DDR2
2 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCLAG00000014757
Gene Symbol: DRD1
3 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSCLAG00000016034
Gene Symbol: DRD2
3 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSCLAG00000014423
Gene Symbol: DRD3
2 Cross references
209 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSCLAG00000001843
Gene Symbol: DRD4
2 Cross references
245 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSCLAG00000006503
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCLAG00000005012
Gene Symbol: EGLN1
3 Cross references
239 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSCLAG00000001036
Gene Symbol: EGLN2
3 Cross references
194 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSCLAG00000010720
Gene Symbol: EGLN3
3 Cross references
208 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSCLAG00000008472
Gene Symbol: ELANE
2 Cross references
91 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSCLAG00000009259
Gene Symbol: EPAS1
3 Cross references
225 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).